Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methyldopa binding to cells in culture.

E Dybing

    Acta Pharmacologica Et Toxicologica
    |January 1, 1977
    PubMed
    Summary

    Rat hepatoma cells activate methyldopa, forming protein adducts. This binding, inhibited by ascorbic acid and glutathione, suggests potential cellular interactions of methyldopa metabolites.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The scientific basis of tobacco product regulation.

    World Health Organization technical report series·2009
    Same author

    Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic--an overview.

    Toxicology letters·2008
    Same author

    Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal.

    Tobacco control·2008
    Same author

    Importance of size and composition of particles for effects on cells in vitro.

    Inhalation toxicology·2007
    Same author

    Particulate matter properties and health effects: consistency of epidemiological and toxicological studies.

    Human & experimental toxicology·2006
    Same author

    Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe.

    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2006

    Area of Science:

    • Biochemistry
    • Cell Biology
    • Toxicology

    Background:

    • Methyldopa is a medication used to treat high blood pressure.
    • Hepatoma cells are cancerous liver cells.
    • Understanding drug metabolism and potential toxicity is crucial.

    Purpose of the Study:

    • To investigate the metabolic activation of methyldopa by rat hepatoma cells.
    • To identify the nature of methyldopa-protein adducts.
    • To assess the mutagenicity of methyldopa and related compounds.

    Main Methods:

    • Culturing rat hepatoma cells.
    • Incubating cells with methyldopa and analyzing protein binding.
    • Testing for inhibition of binding using specific agents like ascorbic acid and glutathione.
    • Performing the Salmonella/mammalian-microsome mutagenicity assay.

    Main Results:

    • Rat hepatoma cells activated methyldopa into intermediates that irreversibly bound to cellular proteins.
    • The binding process was not affected by superoxide dismutase or allopurinol.
    • Ascorbic acid and glutathione significantly inhibited the methyldopa-protein binding.
    • Methyldopa, paracetamol, and furosemide did not exhibit mutagenic effects in the assay.

    Conclusions:

    • Methyldopa can be metabolically activated by hepatoma cells, leading to protein binding.
    • Antioxidants like ascorbic acid and glutathione may play a role in mitigating this binding.
    • Methyldopa, paracetamol, and furosemide appear non-mutagenic under the tested conditions.

    Related Experiment Videos